Related Experiment Videos
Antiepileptic drugs and alpha 1-acid glycoprotein
The New England Journal of Medicine
|October 28, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients.
Scandinavian journal of pain·2018
Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans.
Clinical pharmacology and therapeutics·2015
Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.
Clinical pharmacology and therapeutics·2014
Grapefruit juice inhibits the metabolic activation of clopidogrel.
Clinical pharmacology and therapeutics·2013
A mechanistic, model-based approach to safety assessment in clinical development.
CPT: pharmacometrics & systems pharmacology·2013
Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metabolite.
Clinical pharmacology and therapeutics·2013
Pulmonary Nodules.
The New England journal of medicine·2026
Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.
The New England journal of medicine·2026
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
The New England journal of medicine·2026
Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.
The New England journal of medicine·2026
Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
The New England journal of medicine·2026
Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
The New England journal of medicine·2026
Nanovesicle-formulated Sterculia coccinea Jack (hantap) leaf extract: Estrogen receptor-alpha molecular docking and cytotoxicity in Michigan Cancer Foundation-7 cells.
Journal of advanced pharmaceutical technology & research·2026